gdc

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members
Verzenio Approved as Initial Treatment for Metastatic Breast Cancer
Breast CancerFDA NewsNewsworthy
The CDK4/CDK6 inhibitor Verzenio received a new indication, for use alone or in combination with an aromatase inhibitor, as initial therapy in women with HR-positive, HER2-negative advanced or metastatic breast cancer.
From Silent Voices to “Hear My Voice”: People Living with Metastatic Breast Cancer Are Speaking Out
Breast Cancer
A national advocacy program trains patients with metastatic breast cancer to educate the public about the special needs of patients with advanced breast cancer.
What Are Biomarkers in Breast Cancer, and How Do They Affect My Treatment? Interview with Daniel F. Hayes, MD, FACP, FASCO
Breast CancerCancer BiomarkersCancer Screening
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.
Finding Our Voices, Telling Our Stories: Metastatic Breast Cancer Advocacy
Breast CancerPatient Advocacy
Musa Mayer, breast cancer survivor and advocate, was recently recognized for her 25 years of advocacy on behalf of patients with advanced breast cancer. Read Musa’s inspiring story.
Living Beyond Breast Cancer to Host 12th Annual National Metastatic Breast Cancer Conference in Philadelphia, April 20-22
Breast CancerNewsworthy
Press Releases – April 10, 2018
Hundreds of people with metastatic breast cancer and their caregivers from across the country will attend the 2018 Conference on Metastatic Breast Cancer in Philadelphia on April 20–22, 2018, hosted by Living Beyond Breast Cancer.
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
Breast CancerNewsworthyWeb Exclusives
Web Exclusives – April 7, 2018
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
Drugs for Breast Cancer
Breast Cancer
Here are the financial support services available to patients receiving treatment for Breast Cancer.
Blood-Based Biopsy Can Predict Breast Cancer Recurrence
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.
The Benefit of CDK4/6 Inhibitors Applies Equally to Older Women with Breast Cancer
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts.
Immunotherapy Continues to Gain Momentum in Breast Cancer
Breast CancerWeb Exclusives
Web Exclusives – February 26, 2018
Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab.
Page 2 of 6
Results 11 - 20 of 55

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country